婦人科手術患者におけるより合理的な肺血栓塞栓症予防法の確立を目指した臨床的検討(<特集>第57回シンポジウム: 肺塞栓-その予防と治療-)
スポンサーリンク
概要
- 論文の詳細を見る
Purposes The aims of this study were to clarify the problem of our prophylactic methods for postoperative pulmonary thromboembolism (PTE) and to propose the measures to prevent this complication more efficiently. The present prophylactic method in our department was the combination of intermittent pneumatic compression during and after operation, and anticoagulation after operation. Methods We estimated several markers for coagulation and fibrinolysis in blood samples obtained from the patients who underwent operation for gynecological diseases in our department to estimate the presence or absence of hypercoagulability, which is one of three major factors responsible for the formation of venous thrombi associated with postoperative PTE. Blood samples were obtained once preoperatively and 8 times postoperatively for each patients. The markers examined were TAT (thrombin-antithrombin complex), SFMC (Soluble fibrin monomer complex), D-dimer, AT III (antithrombin III), Protein C, and Protein S. Two coagulation markers, TAT and SFMC correlate with the generation of thrombin and fibrin respectively, both of which are key factors of coagulation system. AT III, Protein C, and Protein S are natural coagulation inhibitors and the deficiency of them is known to be associated with the increased risk of venous thromboembolism. Results We obtained blood samples from 88 patients under informed consent. Two patients developed PTE with the onset at postoperative day 1. Including these 2 cases, postoperative PTE developed in 5 cases during this study. All the cases were under prophylaxis for postoperative PTE, and, then, these PTE cases suggest the weak points of our prophylactic method. In the 2 cases complicated with postoperative PTE, the levels of TAT and SFMC were high immediately after operation and, then, decreased, suggesting that the causative venous thrombi for the PTE were probably formed during operation. To examine whether we can diagnose such cases by the postoperative estimation of the markers, we compared the level of TAT, SFMC, and D-dimer in the 2 cases with postoperative PTE with that of other 86 cases without PTE. The marker levels at 0 hour or 6 hours after operation of the 2 cases with PTE were in higher range, compared with the cases without PTE, though some cases without PTE showed the similar high level with the cases with PTE. Thus, the estimations of coagulation markers seemed to be useful as screening for cases with DVT developed during operation. The estimation of AT III, and Protein C pathways, revealed the transient decrease of them after operation. 58% of cases decreased in either of the two pathways and 29% of cases, in both pathways. The multivariate study revealed that the decrease of the coagulation inhibitors were correlated with the blood loss during operation, operation time and operation size. The deficiency of these pathways seemed to reach abnormal levels during operation, and thus, the decrease of these coagulation inhibitors possibly was associated with the formation of DVT during operation. Conclusions We should cope enough with the generation of DVT with the onset during operation. In our department, we try to begin anticoagulation during operation for patients with very high risk of this complication. The postoperative estimation of coagulation markers may be helpful for the screening of DVT formed during operation. The decrease of natural coagulation inhibitors during operation may be associated with the DVT formation during operation.
- 社団法人日本産科婦人科学会の論文
- 2005-09-01
著者
関連論文
- 原因不明の慢性骨盤痛の治療として腹腔鏡下右子宮円索切断術を施行した2例
- 子宮頸癌発症機構における Human papillomavirus (HPV)の役割と抗 HPV ワクチン療法の開発
- 我々が経験した肺塞栓症症例について
- 子宮筋腫発生機序
- 婦人科手術患者におけるより合理的な肺血栓塞栓症予防法の確立を目指した臨床的検討(第57回シンポジウム: 肺塞栓-その予防と治療-)
- 当科および関係病院で経験した婦人科疾患に合併した重症肺血栓塞栓症10例の解析
- 当科における境界悪性卵巣腫瘍の臨床病理的検討
- 婦人科悪性腫瘍患者治療後の下肢リンパ浮腫について
- 進行子宮頸癌に対する動注化学療法同時併用放射線治療 concurrent chemoradiotherapyの治療成績の検討
- 当科における子宮肉腫診断についての検討 : ─MRI画像診断を中心として─
- 子宮頚部悪性腺腫の病態に関与する因子とその臨床診断への応用に対する検討
- 進行子宮頚癌に対する動注化学療法同時併用放射線治療concurrent chemo‐radiation therapyの実施状況
- 妊娠と卵巣腫よう
- 当科における上皮性卵巣癌の再発例治療の検討
- 難治性子宮体癌に対する術後化学療法についての検討